Search

Your search keyword '"TURA, SANTE"' showing total 757 results
Start Over Author "TURA, SANTE"
757 results on '"TURA, SANTE"'

11. Combined Use of Growth Factors to Stimulate the Proliferation of Hematopoietic Progenitor Cells after Autologous Bone Marrow Transplantation (ABMT) for Lymphoma Patients

Author

Lemoli, Roberto M., Fortuna, Alessandra, Fogli, Miriam, Rosti, Gianantonio, Gherlinzoni, Filippo, Visani, Giuseppe, Catani, Lucia, Gozzetti, Alessandro, Tura, Sante, Abraham, Nader G., editor, Asano, Shigetaka, editor, Brittinger, Günther, editor, Maestroni, Georges J. M., editor, and Shadduck, Richard K., editor

Published
1996
Full Text
View/download PDF

13. Corso di malattie del sangue e degli organi emolinfopoietici

Author

Tura, Sante, Cavo, Michele, Zinzani, Pier Luigi, Broccoli Alessandro, Argnani Lisa, Fiacchini Mauro, Tura, Sante, Cavo, Michele, Zinzani, Pier Luigi, and Broccoli, Alessandro, Argnani, Lisa, Fiacchini, Mauro

Subjects
metodi, ricerca clinica, malattie del sangue, sperimentazione clinica, ricerca scientifica
Abstract

Il metodo della ricerca clinica

Published
2020

16. Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)

Author

Angelucci, Emanuele, Santini, Valeria, Di Tucci, Anna Angela, Quaresmini, Giulia, Finelli, Carlo, Volpe, Antonio, Quarta, Giovanni, Rivellini, Flavia, Sanpaolo, Grazia, Cilloni, Daniela, Salvi, Flavia, Caocci, Giovanni, Molteni, Alfredo, Vallisa, Daniele, Voso, Maria Teresa, Fenu, Susanna, Borin, Lorenza, Latte, Giancarlo, Alimena, Giuliana, Storti, Sergio, Piciocchi, Alfonso, Fazi, Paola, Vignetti, Marco, and Tura, Sante

Published
2014
Full Text
View/download PDF

19. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. (Research)

Author

Herwaldt, Barbara L., Caccio, Simone, Gherlinzoni, Filippo, Aspock, Horst, Slemenda, Susan B., Piccaluga, PierPaolo, Martinelli, Giovanni, Edelhofer, Renate, Hollenstein, Ursula, Poletti, Giovanni, Pampiglione, Silvio, Loschenberger, Karin, Tura, Sante, and Pieniazek, Norman J.

Subjects
Babesiosis -- Research
Abstract

In Europe, most reported human cases of babesiosis have been attributed, without strong molecular evidence, to infection with the bovine parasite Babesia divergens. We investigated the first known human cases [...]

Published
2003

29. Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma

Author

Zinzani, Pier Luigi, Pulsoni, Alessandro, Perrotti, Alessio, Soverini, Simona, Zaja, Francesco, De Renzo, Amalia, Storti, Sergio, Lauta, Vito Michele, Guardigni, Luciano, Gentilini, Patrizia, Tucci, Alessandra, Lia Molinari, Anna, Gobbi, Marco, Falini, Brunangelo, Fattori, Pier Paolo, Ciccone, Fabrizio, Alinari, Lapo, Martelli, Maurizio, Pileri, Stefano, Tura, Sante, and Baccarani, Michele

Published
2004
Full Text
View/download PDF

30. Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial

Author

Martelli, Maurizio, Gherlinzoni, Filippo, De Renzo, Amalia, Zinzani, Pier Luigi, De Vivo, Antonio, Cantonetti, Maria, Falini, Brunangelo, Storti, Sergio, Meloni, Giovanna, Rizzo, Manuela, Molinari, Anna Lia, Lauria, Francesco, Moretti, Luciano, Lauta, Vito Michele, Mazza, Patrizio, Guardigni, Luciano, Pescarmona, E., Pileri, S.A., Mandelli, Franco, and Tura, Sante

Published
2003

32. Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation

Author

Soverini, Simona, Cavo, Michele, Cellini, Claudia, Terragna, Carolina, Zamagni, Elena, Ruggeri, Deborah, Testoni, Nicoletta, Tosi, Patrizia, de Vivo, Antonio, Amabile, Marilina, Grafone, Tiziana, Ottaviani, Emanuela, Giannini, Barbara, Cangini, Delia, Bonifazi, Francesca, Neri, Antonino, Fabris, Sonia, Tura, Sante, Baccarani, Michele, and Martinelli, Giovanni

Published
2003
Full Text
View/download PDF

39. Randomized Trial of Fludarabine Versus Fludarabine and Idarubicin as Frontline Treatment in Patients With Indolent or Mantle-Cell Lymphoma

Author

Zinzani, Pier Luigi, Magagnoli, Massimo, Moretti, Luciano, De Renzo, Amalia, Battista, Raffaele, Zaccaria, Alfonso, Guardigni, Luciano, Mazza, Patrizio, Marra, Roberto, Ronconi, Fioravante, Lauta, Vito Michele, Bendandi, Maurizio, Gherlinzoni, Filippo, Gentilini, Patrizia, Ciccone, Fabrizio, Cellini, Claudia, Stefoni, Vittorio, Ricciuti, Francesco, Gobbi, Marco, and Tura, Sante

Published
2000

40. Allogenic bone marrow transplantation in multiple myeloma

Author

Gahrton, Gosta, Tura, Sante, Ljungman, Per, Belanger, Coralie, Brandt, Lena, Cavo, Michele, Facon, Thierry, Granena, Alberto, Gore, Martin, Gratwohl, Alois, Lowenberg, Bob, Nikoskelainen, Jukka, Reiffers, Josy J., Samson, Diana, Verdonck, Leo, and Volin, Liisa

Subjects
Bone marrow -- Transplantation, Multiple myeloma -- Care and treatment
Abstract

Multiple myeloma results from the tumor-like growth of bone marrow cells. At present, the condition is generally fatal. However, there are indications that chemotherapy may be effective if greater doses and more aggressive drug combinations are used. However, the doses of chemotherapeutic agents that can be used are limited by destruction of normal bone marrow cells, a dangerous side effect. One method of circumventing this problem is to use a dose of drugs that virtually ablates the bone marrow, followed by bone marrow transplantation from a closely matched donor. This method has now been used to treat 90 patients with multiple myeloma. After a follow-up period of 79 months, 47 patients were still alive, and the remainder had died. Ten patients died soon after the bone marrow transplantation. Of the remaining patients, 37 had no signs of graft-versus-host disease (GVHD), in which the bone marrow of the donor attacks the tissues of its new host. Twenty-two patients had grade I GVHD, 10 had grade II, four had grade III, and four had grade IV GVHD. Patients with grade I GVHD or without GVHD were more likely to survive than patients with more extensive GVHD. Achieving a complete remission after bone marrow transplantation was also a significant predictor of long-term survival. The results of this study indicate that bone marrow transplantation from a carefully matched sibling may be an important treatment for some patients with multiple myeloma. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1991

50. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias

Author

Ottmann, Oliver G., Druker, Brian J., Sawyers, Charles L., Goldman, John M., Reiffers, Jose, Silver, Richard T., Tura, Sante, Fischer, Thomas, Deininger, Michael W., Schiffer, Charles A., Baccarani, Michele, Gratwohl, Alois, Hochhaus, Andreas, Hoelzer, Dieter, Fernandes-Reese, Sofia, Gathmann, Insa, Capdeville, Renaud, and O'Brien, Stephen G.

Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results